Eargo to Present at 39th Annual J.P. Morgan Healthcare Conference

SAN JOSE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the 39^th Annual J.P. Morgan Healthcare Conference via web cast. Christian Gormsen, Eargo’s President and Chief Executive Officer, is scheduled to present on Tuesday, January 12^th at 2:00pm Eastern Time.

The live web cast of Eargo’s presentation, along with accompanying slides, can be accessed at www.eargo.com and will be available for replay through February 12, 2021.

About Eargo
Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. Our innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first and only virtually invisible, rechargeable, completely-in-canal, FDA regulated, exempt Class I device for the treatment of hearing loss. Our differentiated, consumer-first solution empowers consumers to take control of their hearing. Consumers can purchase online or over the phone and get personalized and convenient consultation and support from licensed hearing professionals via phone, text, email or video chat. The Eargo solution is offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.

The company’s 4^th generation product, the Eargo Neo HiFi, was launched in January and features improved capabilities across audio fidelity and bandwidth. The Eargo Neo HiFi is available for purchase here.

Related Links
http://eargo.com

Investor Contact
Nick Laudico
Vice President of Investor Relations
[email protected]

Media Contact
Brad Sheets
[email protected]

You May Also Be Interested In

• NICE Supports Routine NHS Funding and Access to Ex-Situ Machine Perfusion in a Major Step Forward for Liver Transplantation
• 49/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
• Arcadis share capital reduction becomes effective